Spots Global Cancer Trial Database for A Study of Adjuvant Melanoma Stakeholder Treatment Preferences
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of Adjuvant Melanoma Stakeholder Treatment Preferences
Official Title: Adjuvant Melanoma Stakeholder Treatment Preference Study
Study ID: NCT05115006
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to understand the trade-offs that participants with surgically treated melanoma would be willing to make among key features and outcomes of adjuvant anti-cancer treatments or no adjuvant treatment / observation.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Local Institution, Melbourne, Victoria, Australia
Contact Details
Name: Bristol-Myers Squibb
Affiliation: Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
